Year |
Citation |
Score |
2020 |
Yuede CM, Wallace CE, Davis TA, Gardiner WD, Hettinger JC, Edwards HM, Hendrix RD, Doherty BM, Yuede KM, Burstein ES, Cirrito JR. Pimavanserin, a 5HT receptor inverse agonist, rapidly suppresses Aβ production and related pathology in a mouse model of Alzheimer's disease. Journal of Neurochemistry. PMID 33278025 DOI: 10.1111/jnc.15260 |
0.536 |
|
2020 |
Hendrix RD, Ou Y, Davis JE, Odle AK, Groves TR, Allen AR, Childs GV, Barger SW. Alzheimer amyloid-β- peptide disrupts membrane localization of glucose transporter 1 in astrocytes: implications for glucose levels in brain and blood. Neurobiology of Aging. 97: 73-88. PMID 33161213 DOI: 10.1016/j.neurobiolaging.2020.10.001 |
0.579 |
|
2019 |
Kulas JA, Franklin WF, Smith NA, Manocha GD, Puig KL, Nagamoto-Combs K, Hendrix RD, Taglialatela G, Barger SW, Combs CK. Corrigendum: Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues (Am J Physiol Endocrinol Metab, (2019) 316, (E106-E120), 10.1152/ajpendo.00279.2018) American Journal of Physiology-Endocrinology and Metabolism. 316. PMID 30721099 DOI: 10.1152/Ajpendo.Zh1-8043-Corr.2019 |
0.551 |
|
2018 |
Kulas JA, Franklin W, Smith NA, Manocha GD, Puig KL, Nagamoto-Combs K, Hendrix RD, Taglialatela G, Barger SW, Combs CK. Ablation of Amyloid Precursor Protein Increases Insulin Degrading Enzyme Levels and Activity in Brain and Peripheral Tissues. American Journal of Physiology. Endocrinology and Metabolism. PMID 30422705 DOI: 10.1152/Ajpendo.00279.2018 |
0.615 |
|
2018 |
Ayyadevara S, Ganne A, Hendrix RD, Balasubramaniam M, Shmookler Reis RJ, Barger SW. Functional assessments through novel proteomics approaches: Application to insulin/IGF signaling in neurodegenerative disease. Journal of Neuroscience Methods. PMID 30412730 DOI: 10.1016/J.Jneumeth.2018.11.005 |
0.525 |
|
Show low-probability matches. |